Inventor · disambiguated record
Vikram Pattanayak
Also filed as: PATTANAYAK VIKRAM
19 granted patents·1 pending application·964 citations·filing 2012–2021
96Inventor score
Top patents by PatentIndex Score
20 records- 0199US10508298B2Methods for identifying a target site of a CAS9 nucleaseHARVARD COLLEGE·Filed 2015·Granted Dec 17, 2019·65 cites·31 claims
- 0299US9163284B2Methods for identifying a target site of a Cas9 nucleaseHARVARD COLLEGE·Filed 2014·Granted Oct 20, 2015·119 cites·24 claims
- 0398US11920181B2Nuclease profiling systemHARVARD COLLEGE·Filed 2021·Granted Mar 5, 2024·20 cites·22 claims
- 0498US11046948B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2019·Granted Jun 29, 2021·64 cites·19 claims
- 0598US10954548B2Nuclease profiling systemHARVARD COLLEGE·Filed 2014·Granted Mar 23, 2021·59 cites·23 claims
- 0698US10526591B2Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Jan 7, 2020·19 cites·32 claims
- 0798US10093910B2Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Oct 9, 2018·26 cites·30 claims
- 0898US9926546B2Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Mar 27, 2018·52 cites·32 claims
- 0998US9512446B1Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2016·Granted Dec 6, 2016·164 cites·27 claims
- 1097US10633642B2Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2018·Granted Apr 28, 2020·12 cites·27 claims
- 1197US10227581B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2014·Granted Mar 12, 2019·86 cites·16 claims
- 1297US9359599B2Engineered transcription activator-like effector (TALE) domains and uses thereofHARVARD COLLEGE·Filed 2014·Granted Jun 7, 2016·95 cites·28 claims
- 1397US9322006B2Evaluation and improvement of nuclease cleavage specificityHARVARD COLLEGE·Filed 2014·Granted Apr 26, 2016·93 cites·26 claims
- 1496US10323236B2Evaluation and improvement of nuclease cleavage specificityLIU DAVID R·Filed 2012·Granted Jun 18, 2019·70 cites·17 claims
- 1595US12006520B2Evaluation and improvement of nuclease cleavage specificityHARVARD COLLEGE·Filed 2019·Granted Jun 11, 2024·18 cites·23 claims
- 1692US11060078B2Engineered CRISPR-Cas9 nucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Jul 13, 2021·2 cites·29 claims
- 1773US2021355465A1Engineered CRISPR-Cas9 NucleasesMASSACHUSETTS GEN HOSPITAL·Filed 2021·Application pending·0 cites
- 1868US11898203B2Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agentsMASSACHUSETTS GEN HOSPITAL·Filed 2019·Granted Feb 13, 2024·0 cites·14 claims
- 1965US11976324B2Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted May 7, 2024·0 cites·17 claims
- 2065US11845987B2Highly sensitive in vitro assays to define substrate preferences and sites of nucleic acid cleaving agentsMASSACHUSETTS GEN HOSPITAL·Filed 2020·Granted Dec 19, 2023·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Vikram Pattanayak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →